EAN Programme Committee Member, Prof. Riccardo Soffietti, talks about unmet needs and what he considers will be the most exciting/promising developments in neuro-oncology over the next 2 years. Part 2 of 3.
View Part 1 here.
View Part 3 here.
Speaker disclosures: nothing to disclose in relation to this video interview.
Filmed at the 3rd Congress of the European Academy of Neurology (EAN), Amsterdam, June 2017.
Trending Topic
Riccardo Soffietti (EAN Programme Committee; Chairman, Department of Neuro-Oncology, University and City of Health and Science Hospital, Turini, Italy) talks to us about the topic of the symposium he participated in entitled: Advances in molecular characterisation and personalised therapies in brain tumours. Part 2 of 2. Questions 1. What are the most promising agents targeting […]
Riccardo Soffietti (EAN Programme Committee; Chairman, Department of Neuro-Oncology, University and City of Health and Science Hospital, Turini, Italy) talks to us about the topic of the symposium he participated in entitled: Advances in molecular characterisation and personalised therapies in ...
EAN Programme Committee Member, Prof. Riccardo Soffietti, provides his insights on neuro-oncology coverage at this year’s EAN congress. Part 3 of 3. View Part 1 here. View Part 2 here. Speaker disclosures: nothing to disclose in relation to this video interview. Filmed at ...
EAN Programme Committee Member, Prof. Riccardo Soffietti, discusses the most significant recent developments in neuro-oncology. Part 1 of 3. View Part 2 here. View Part 3 here. Speaker disclosures: nothing to disclose in relation to this video interview. Filmed at the 3rd Congress of ...
M.M. Thurnher discusses brain tumour radiology at ECR 2014.
Kurt Jaeckle, MD, professor of neurology and oncology, Mayo Clinic, discusses radiosurgery versus radiotherapy followed by whole brain radiation for brain metastases.
Dr Buckner (Mayo Clinic, Rochester, USA) presents, at a press conference at ASCO 2015, a federally funded phase III trial that is providing additional information regarding a long-standing discussion about the impact of adjuvant whole brain radiation therapy (WBRT) on cognitive ...
Demonstration of the benefits and limitations of fluorescent guided surgery for resection of glioblastoma.
The UF Health Cancer Center at Orlando is one of very few centers in the southeast to offer dedicated neuro oncology, neuro radiation oncology, and tumor neurosurgery teams that specialize in treating brain and spine tumors.
From ASCO 2014, Dr. Annick Desjardins of Duke University discusses the retrospective focus on glioblastoma treatment and the use of bevacizumab.
The ways in which mice can be used to investigate the causes of malignant brain tumours.
Susan Challinor, MD, an endocrinologist at UPMC, discusses the diagnosis and treatment of pituitary adenomas and details why a multidisciplinary approach should be considered.
Glioblastoma (GBT) is the most prevalent and most aggressive form of cancers of the brain and nervous systems. GBT is a dismal disease with one year survival rates at 30% and five year survival rates at 3%.
Keep track of your clinical interests and newsletter subscriptions.
Or use a .
Already registered? Login below.
